3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Down Syndrome
2
Blast Crisis
2
Renal Pelvis and Ureter Urothelial Carcinoma
1
Osteosarcoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Temozolomide
6
Radiosurgery
6
pembrolizumab
4
Magnetic Resonance Spectroscopy
4
Bevacizumab
4
Specimen Handling
3
Nivolumab
3
abemaciclib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Receptors, Interleukin-8B
2
Radiation
2
Mental Status and Dementia Tests
2
Memantine
2
Ipilimumab
2
Biopsy
2
vorasidenib
1
sotorasib
1
sapanisertib
1
ribociclib
1
pertuzumab
1
osimertinib
1
lenvatinib
1
fluciclovine F-18
1
entrectinib
1
encorafenib
1
elacestrant
1
brivaracetam
1
binimetinib
1
Valacyclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
merphos
×
30 days
×
Clear all
No trials found.